Barry Labinger, EVP, Biosciences Division at Emergent BioSolutions Inc. (EBS), sold 37,797 shares at $35.51 ($1.3M) on 2015-11-11, disclosed to the SEC on 2015-11-13.
Open-market sale of $1.3M EBS by EVP, Biosciences Division. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.50 | 9,373 | $333K | 24.7% |
| 2 | $35.50 | 10,095 | $358K | 26.6% |
| 3 | $35.51 | 6,564 | $233K | 17.3% |
| 4 | $35.88 | 1,671 | $60K | 4.4% |
| 5 | $36.00 | 10,094 | $363K | 27.0% |
| Total | $35.65 avg | 37,797 |
| $1.3M |
| 100% |
| Filing → |
| HGSI | SELL | 2011-04-29 | $1.2M | — | Filing → |
| HGSI | SELL | 2010-09-02 | $1.5M | — | Filing → |
| HGSI | SELL | 2010-08-30 | $831K | — | Filing → |